Paradoxical case effects of psoriasis following adalimumab therapy: A case series

Dermatol Ther. 2018 Nov;31(6):e12729. doi: 10.1111/dth.12729. Epub 2018 Sep 21.

Authors

Arianna Zangrilli¹, Mauro Bavetta¹, Sara Mazzilli¹, Virginia Garofalo¹, Luca Bianchi¹

Affiliation

¹ Department of Dermatology, University Hospital of Tor Vergata, Rome, Italy.

PMID: 30239070
DOI: 10.1111/dth.12729

No abstract available

Publication types

Letter

MeSH terms

Adalimumab / adverse effects*
Adult
Aged
Anti-Inflammatory Agents / adverse effects*
Biological Products / adverse effects*
Disease Progression
Female
Humans
Male
Middle Aged
Psoriasis / diagnosis
Psoriasis / drug therapy*
Psoriasis / immunology
Remission Induction
Risk Factors
Skin / drug effects*
Skin / immunology
Skin / pathology
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / immunology

Substances

Anti-Inflammatory Agents
Biological Products
Tumor Necrosis Factor-alpha
Adalimumab